Skip to content

A comparative study between two anaesthetic drugs for shock treatment.

A comparative study between Propofol and Thiopentone for modified Electroconvulsive therapy.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042213
Enrollment
60
Registered
2022-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F323- Major depressive disorder, singleepisode, severe with psychotic features

Interventions

Intervention1: Propofol : Propofol 1mg/kg body weight, intravenous route of administration single stat dose Control Intervention1: Thiopentone: Thiopentone 2.5mg/kg body weight intravenous route of a

Sponsors

Dr Swapna Vankadara
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade 2and 3

Exclusion criteria

Exclusion criteria: ASA Grade 4

Design outcomes

Primary

MeasureTime frame
Duration of seizure activity after Electro convulsive therapy. Recovery time from the anaesthetic agent post electroconvulsive therapy.Timepoint: Duration of seizure activity immediately post Electroconvulsive therapy to be recorded for every 20seconds,30 seconds,60 seconds and 180 seconds. Recovery time from the anaesthetic agent to be recorded after electroconvulsive therapy for3 minutes 5minutes,7 minutes and 10 minutes.

Secondary

MeasureTime frame
Haemodynamic changesTimepoint: Basal,After induction, 1 minute,2,3,5minutes,10,20,30 minutes following ECT

Countries

India

Contacts

Public ContactDr Bhavana

Narayana medical college

drvkswapna@gmail.com9966634281

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026